# P3–P9 Execution Authorization Record

**Record ID:** AUTH-P3-P9-001  
**Decision timestamp:** 2026-11-14T20:25:51+07:00 (Asia/Jakarta)  
**Approver role:** Project owner; the explicit instruction was received in the active conversation.  
**Scope:** P3 through P9 of the P0–P9 Research-to-Execution Pipeline.

## Authorization evidence

The project owner explicitly instructed: **“P3–P9 saya beri otorisasi”** on 2026-11-14, together with the instruction to continue the existing project. This record formalizes that instruction as a standing, phase-scoped authorization for P3, P4, P5, P6, P7, P8 and P9.

## Activation and dependency rules

The authorization is granted for the listed phases, but it does not waive sequential prerequisites:

| Phase | Authorized scope | Activation gate |
|---|---|---|
| P3 — Cross-Domain Synthesis | Evidence-linked synthesis of accepted P1 and P2 materials | P2 must be `COMPLETE_AND_APPROVED`; satisfied after APR-P2-001 |
| P4 — University Compliance | Official-guideline registry and testable compliance profiles | P3 must be validated, human-accepted and `COMPLETE_AND_APPROVED` |
| P5 — Methodology & Data Validity | Discipline-appropriate design/data consistency validation | P4 must be `COMPLETE_AND_APPROVED` |
| P6 — Evidence, Citation & Ethics | Claim-source traceability, citation and ethics controls | P5 must be `COMPLETE_AND_APPROVED` |
| P7 — Semantic & Humanized Writing | Natural academic language, reasoning and voice QA without detector evasion | P6 must be `COMPLETE_AND_APPROVED` |
| P8 — Repository & Execution Engineering | Production architecture, isolation, workflows, integration and reproducibility | P7 must be `COMPLETE_AND_APPROVED` |
| P9 — Red-Team & Final Prompt Compilation | Adversarial validation, cross-domain acceptance and final prompt/configuration | P8 must be `COMPLETE_AND_APPROVED` |

P3 is activated now because P2 has been accepted and its predecessor requirements are satisfied. P4–P9 are recorded as **conditionally pre-authorized**. They may remain `NOT_STARTED` while the immediate predecessor is incomplete; their authorization must not be interpreted as permission to bypass the gate.

## Execution controls

1. Execute research phases in order. The active execution unit is one phase; do not start P4 in the same execution unit as P3.
2. Every phase retains separate execution, validation, human-acceptance, approval and authorization states.
3. Do not set a phase to complete or approved until its predecessor is complete and approved and its own validation and human acceptance are recorded.
4. Do not invent independent reviewers, ethical approvals, institutional requirements, citations, source access or full-text evidence.
5. Keep P1/P2 record-level datasets, source locators, abstracts and private evidence packages out of the public repository.
6. Remote merge, release, deployment, public data publication, or irreversible external side effects are not authorized by this phase-execution record.

## Current effective state

- P2: `COMPLETE_AND_APPROVED` under scoped acceptance APR-P2-001.
- P3: authorized and eligible to execute; synthesis candidate generated, validation `PASS_WITH_LIMITATION`, human acceptance pending.
- P4–P9: authorized conditionally, but not started; each remains gated by immediate-predecessor acceptance.

This authorization remains valid for the listed phase scopes. It does not constitute acceptance of any future phase output.
